Memorial Sloan Kettering Cancer Center

This small pilot study tested a drug called BGJ398 in 4 people with a type of bladder cancer that stayed in the bladder lining but came back after standard treatment. The goal was to see if the drug could make the tumor disappear. The study is complete, but results are not yet re…

This early-phase study looked at adding the immunotherapy drugs nivolumab (with or without ipilimumab) to standard chemotherapy for people with advanced high-grade serous ovarian, fallopian tube, or primary peritoneal cancer. The main goal was to see if the combination was safe a…

This study tested a new type of PET scan that uses a radioactive tracer called 89Zr-DFO-huJ591 to find prostate cancer that has spread to other parts of the body, especially the bones. 77 men with metastatic prostate cancer received both the experimental scan and standard scans (…

This study tested a special therapy called Managing Anxiety from Cancer (MAC) to see if it helps reduce anxiety in older adults (65+) with cancer and their caregivers. 26 people took part, and the therapy was compared to usual care. The goal was to improve emotional well-being an…

This study looked at 133 Hodgkin lymphoma survivors who had chest radiation at least 5 years ago. Researchers compared two heart tests—cardiac MRI and stress echocardiogram—to see which one finds heart damage earlier. The goal is to improve long-term heart monitoring for survivor…

This study looked at whether screening cancer caregivers for distress and then providing targeted support (the S+C approach) is better than usual care. About 150 caregivers of cancer patients took part. The goal was to see if this approach reduces caregivers' unmet needs and impr…